IE 11 is not supported. For an optimal experience visit our site on another browser.

Experimental coronavirus drug remdesivir gets emergency FDA authorization


Gilead Sciences, the company behind the antiviral drug, says it will be donating 1.5 million vials to the federal government. Early results from the NIH controlled trial show patients taking remdesivir improved faster than those taking a placebo, but the full study has not been published.